Prelude Therapeutics Incorporated (PRLD)
Nasdaq: PRLD · Pharmaceutical Preparations · Wilmington, DE · filing with the SEC since 2016
Filings
203 filings since 2017 beside 185 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 42 days after the quarter ended. The proxy statement was last filed Apr 29, 2026.
Filings a yearinsider forms included
151863858555443
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Apr 15, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Mar 28, 2025.SEC letters: 7 in the last 36 months, the newest Dec 15, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
May 12, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 21, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Apr 20, 2026
Apr 20, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 10, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 12, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 4, 2025
8-K items 1.01, 3.02, 5.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Officer or director change; Investor disclosure (Regulation FD) · Current report
Nov 3, 2025
Oct 17, 2025
8-K items 5.02, 7.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Oct 15, 2025
Aug 14, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Jun 13, 2025
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
Jun 11, 2025
40 of 203 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.